CoChat

Anti‐PD‐1 synergizes with cyclophosphamide to induce potent anti‐tumor vaccine effects through novel mechanisms

Open access
Mkrtichyan, Mikayel, Najjar, Yana G., Raulfs, Estella C., Abdalla, Maher Y., Samara, Raed, Rotem‐Yehudar, Rinat, Cook, Larry, Khleif, Samir N. · 2011 · European Journal of Immunology
Cited by 144

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Programmed death‐1 receptor (PD‐1) is expressed on T cells following TCR activation. Binding of this receptor to its cognate ligands, programmed death ligand (PDL)‐1 and PDL‐2, down‐regulates signals by the TCR, promoting T‐cell anergy and apoptosis, thus leading to immune suppression. Here, we find that using an anti‐PD‐1 antibody (CT‐011) with Treg‐cell depletion by low‐dose cyclophosphamide (CPM), combined with a tumor vaccine, induces synergistic antigen‐specific immune responses and reveals novel activities of each agent in this combination. This strategy led to complete regression of established tumors in a significant percentage of treated animals, with survival prolongation. We show for the first time that combining CT‐011 and CPM significantly increases the number of vaccine‐induced tumor‐infiltrating CD8+ T cells, with simultaneous decrease in infiltrating Treg cells. Interestingly, we find that CT‐011 prolongs Treg‐cell inhibition induced by CPM, leading to a sustainable significant synergistic decrease of splenic and tumor‐infiltrated Treg cells. Surprisingly, we find that the anti‐tumor effect elicited by the combination of CT‐011 and CPM is dependent on both CD8+ and CD4+ T‐cell responses, although the antigen we used is a class I MHC‐restricted peptide. Thus, we describe a novel and effective therapeutic approach by combining multiple strategies to target several tumor‐mediated immune inhibitory mechanisms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/eji.201141639

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 144

Metadata

Authors
Mkrtichyan, M., Najjar, Y. G., Raulfs, E. C., Abdalla, M. Y., Samara, R., Rotem‐Yehudar, R., Cook, L., & Khleif, S. N.
Venue
European Journal of Immunology
Publisher
Wiley
Published
2011-08-17
Volume
41
Issue
10
Pages
2977-2986
ISSN
  • 0014-2980 (ISSN-L)
  • 1521-4141
OpenAlex
W1964080141
Cited by
144
References
13
FWCI
5.24
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.